e-SPACE Heart Failure 2024
Published: 28 October 2024
-
Views:
176 -
Likes:
7
-
Views:
176 -
Likes:
7
-
Up Next
-
1h 10m 15sPart 1 | Session 6 Plenary session 4 – Managing cardiomyopathy in HF
-
1h 4m 48sPart 1 | Session 7 Plenary session 5 – Cardiac rhythm in HF
-
1h 13m 18sPart 1 | Session 8 Plenary session 6 – Devices in HF; time to reassess their place?
-
58m 32sPart 2 | Session 1 Plenary session 7 – Enabling GDMT in HF
-
1h 54sPart 2 | Session 2 Plenary session 8 – Iron deficiency: the totality of evidence
-
59m 41sPart 2 | Session 3 Plenary session 9 – Managing HFpEF in 2024
-
1h 45sPart 2 | Session 4 Plenary session 10 – Valvular heart disease
-
59m 47s
-
1h 57sPart 1 | Session 1 Plenary session 1 – Practical implementation of GDMT in the clinical setting Vijay Chopra, Tarek Bekfani, Gianluigi Savarese, Jasper J Brugts, Justin Ezekowitz
-
1h 2m 9sPart 1 | Session 2 Plenary session 2 – SGLT2s in clinical practice John J Atherton, Tarek Bekfani, Javed Butler, Clara Saldarriaga, Faiez Zannad
-
1h 7m 6sPart 1 | Session 3 Special session 1 – Cardiac rhythm management devices: cornerstones of comprehensive, patient-centred HF care The-DIRECT-HF initiative (The DIRECT HF educational programme is supported by Medtronic) Biykem Bozkurt, Javed Butler, Giuseppe Rosano, Gianluigi Savarese, Shelley Zieroth
-
59m 29sPart 1 | Session 4 Plenary session 3 – Obesity and weight management in HF Stefan Anker, Petar M Seferovic, Naveed Sattar, Shelley Zieroth, Shahzeb Khan, Peter Rossing
Overview
Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure held on the 18-19 October 2024.
e-SPACE Heart Failure 2024 once again provided top-tier free virtual education and optimised geographical reach whilst delivering both global and regional insight. The thoughtfully curated programme explored how leading experts are incorporating heart failure guidelines into clinical practice and offered the latest information on patient profiling in heart failure for tailored medical therapy.
Building on the tremendous success of previous years, this event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Related sessions to e-SPACE Heart Failure 2024:
- Meet the Experts: SGLT2 Inhibitors in Real Life: Everything the Clinician Needs to Know
- Meet the Experts: GDMT Implementation in HF: How to Tackle Clinical Inertia?
- Meet the Experts: Management of Transthyretin Amyloid Cardiomyopathy (ATTRCM): Optimising Patient Pathways
- Meet the Experts: IV Iron in Clinical Practice: Experts’ Perspectives
- Meet the Experts: Hyperkalemia in HF: Clinical Impact and Long-term Management
- Symposium: SGLT2 Inhibitors in Heart Failure: Updates on Prevention and Treatment
- Meet the Experts: Non-steroidal MRAs: Evolving Role in Heart Failure
Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day One
Part 2
Day Two
Faculty Biographies
Thibaud Damy
Professor Thibaud Damy is a cardiologist focusing on heart failure and cardiac amyloidosis. He works at Hospital Henri Mondor and Paris East Creteil University (UPEC), and is part of INSERM U955. Prof Damy leads the Referral Center for Cardiac Amyloidosis and the French National Amyloidosis Network, which includes a registry of about 4,500 patients.